CYTOKINETICS, INCORPORATED Debt Securities, Available-for-sale
CYTOKINETICS, INCORPORATED (CYTK) had Debt Securities, Available-for-sale of $825.59 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2023-03-01
- 2022-12-31: Debt Securities, Available-for-sale $825.59M.
- 2022-09-30: Debt Securities, Available-for-sale $895.43M.
- 2022-06-30: Debt Securities, Available-for-sale $595.39M.
- 2022-03-31: Debt Securities, Available-for-sale $682.53M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2022-12-31 | $825.59M 10-K · filed 2023-03-01 |
| 2022-09-30 | $895.43M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $595.39M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $682.53M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $626.96M 10-K · filed 2023-03-01 |
| 2021-09-30 | $666.61M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $422.22M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $453.19M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $498.08M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |